tried telehealth for 15 weeks. here is what happened.
I have had 5 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 10 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 93.7% against a claimed 98.6%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
no pharmacy referral codes, naming is fine, recruiting is not
no pharmacy referral codes, naming is fine, recruiting is not
Disagree on that part. 98.9% and 99.0% on the same vial is normal.
This is correct. The shortage list does expire and the rules change.
the shortage list is temporary, it ends and compounding becomes illegal again
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
the shortage list is temporary, it ends and compounding becomes illegal again
Slight fix: the number was 97.6, not 97.4. Decimal point, but a fairly consequential one.
Not convinced. The evidence does not support that reading.
shortage list status is shortage list, check the actual list
Yeah, 503A and 503B are different regulatory animals.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
state board rules differ, say which state
telehealth prescriber models exist, pricing differs by state
no pharmacy referral codes, naming is fine, recruiting is not
Rodent data is rodent data.
Adding to this: shortage list is doing more work than the comment implies.
the shortage list is temporary, it ends and compounding becomes illegal again
regulatory claims need a citation to the actual rule, not interpretation
Slight fix: the number was 98.7, not 99.3. Decimal point, but a fairly consequential one.
The telehealth + compounding combo cost state board plus 16% markup. Not cheap but covered by insurance depending on state.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
503B compounding is different from 503A, different rules, different legality
Tracking number removed. It identifies both ends of a shipment.
state board rules differ, say which state
Strongly agree. API source transparency matters.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
the 503A/503B distinction is load-bearing, do not blur it
The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.
Strongly agree. API source transparency matters.
The telehealth + compounding combo cost state board plus 7% markup. Not cheap but covered by insurance depending on state.
- 1Yeah, 503A and 503B are different regulatory animals.11 comments in this branch · started by u/rekha_mwangi
- 2Inter-lab variance on this kind of assay is routinely 1–2 points. Different…7 comments in this branch · started by u/lukas_vermeulen